INSIDER
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProMethodologyMatch reviewLaunch readiness
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProMethodologyMatch reviewLaunch readiness
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 411m ago
HOUSE PTR11m ago
SEC 13F11m ago
ROBINHOOD CHAIN10m ago
SEC FORM 4/Tax withholdingVerified data

Acurio Veronica reported NVST

President, Orthodontics · Envista Holdings Corp · Common Stock

Side
F
Value
$212K
Shares
7,710
Price
$27.47
Executed
Aug 25, 2026
Disclosed
Aug 27, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Aug 25 executedAug 27, 2026 disclosed

NVST · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
16/ 100 · ROUTINE
Methodology →
  • Transaction type0 / 20

    Tax withholding — administrative, little informational value

  • Relative size+8 / 25

$212K reported value · 18.8% of prior position

  • Filing timing0 / 15

    Disclosed 2 business days after execution (deadline: 2)

  • Historical behavior+8 / 15

    First recorded trade by this actor in this security

  • Frequency & clustering0 / 15

    No clustered activity in the dataset

  • Market events0 / 10

    No material company filing within 60 days after the trade

    • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · NVST

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    16
    BR
    Befidi RobertPresident, Diagnostics
    NVSTEnvista Holdings Corp
    Tax withholding
    		F$141K
    5,147 sh
    		Aug 25, 2026Aug 27, 2026
    traded Aug 25, 2026
    		+2dSEC FORM 4

    Evidence

    9
    NS
    Nilsson StefanPresident, Nobel Biocare
    NVSTEnvista Holdings Corp
    Tax withholding
    		F$22K
    804 sh
    		Aug 25, 2026Aug 27, 2026
    traded Aug 25, 2026
    		+2dSEC FORM 4

    Evidence

    16
    RM
    Reis MischaSVP, Strategy & Bus. Dev.
    NVSTEnvista Holdings Corp
    Open-market sale · 10b5-1 plan
    		SELL$220K
    8,000 sh
    		Aug 20, 2026Aug 24, 2026
    traded Aug 20, 2026
    		+4dSEC FORM 4

    Evidence

    9
    AV
    Acurio VeronicaPresident, Orthodontics
    NVSTEnvista Holdings Corp
    Grant or award
    		A—
    18.0K sh
    		Feb 25, 2026Feb 27, 2026
    traded Feb 25, 2026
    		+2dSEC FORM 4

    Evidence

    9
    NS
    Nilsson StefanPresident, Nobel Biocare
    NVSTEnvista Holdings Corp
    Tax withholding
    		F$5,385
    182 sh
    		Feb 25, 2026Feb 27, 2026
    traded Feb 25, 2026
    		+2dSEC FORM 4

    Evidence

    13
    NS
    Nilsson StefanPresident, Nobel Biocare
    NVSTEnvista Holdings Corp
    Grant or award
    		A—
    7,605 sh
    		Feb 25, 2026Feb 27, 2026
    traded Feb 25, 2026
    		+2dSEC FORM 4

    Evidence

    9
    NS
    Nilsson StefanPresident, Nobel Biocare
    NVSTEnvista Holdings Corp
    Grant or award
    		A—
    13.8K sh
    		Feb 25, 2026Feb 27, 2026
    traded Feb 25, 2026
    		+2dSEC FORM 4

    Evidence

    16
    BR
    Befidi RobertPresident, Diagnostics
    NVSTEnvista Holdings Corp
    Tax withholding
    		F$64K
    2,177 sh
    		Feb 25, 2026Feb 27, 2026
    traded Feb 25, 2026
    		+2dSEC FORM 4

    Evidence

    13
    BR
    Befidi RobertPresident, Diagnostics
    NVSTEnvista Holdings Corp
    Grant or award
    		A—
    7,605 sh
    		Feb 25, 2026Feb 27, 2026
    traded Feb 25, 2026
    		+2dSEC FORM 4

    Evidence

    9
    BR
    Befidi RobertPresident, Diagnostics
    NVSTEnvista Holdings Corp
    Grant or award
    		A—
    13.8K sh
    		Feb 25, 2026Feb 27, 2026
    traded Feb 25, 2026
    		+2dSEC FORM 4

    Evidence

    9
    BR
    Befidi RobertPresident, Diagnostics
    NVSTEnvista Holdings Corp
    Grant or award
    		A—
    18.0K sh
    		Feb 25, 2026Feb 27, 2026
    traded Feb 25, 2026
    		+2dSEC FORM 4

    Evidence

    16
    KC
    Kaabi Faez CChief Accounting Officer
    NVSTEnvista Holdings Corp
    Tax withholding
    		F$147K
    4,964 sh
    		Feb 25, 2026Feb 27, 2026
    traded Feb 25, 2026
    		+2dSEC FORM 4

    Evidence

    17
    KC
    Kaabi Faez CChief Accounting Officer
    NVSTEnvista Holdings Corp
    Grant or award
    		A—
    13.5K sh
    		Feb 25, 2026Feb 27, 2026
    traded Feb 25, 2026
    		+2dSEC FORM 4

    Evidence

    9
    NS
    Nilsson StefanPresident, Nobel Biocare
    NVSTEnvista Holdings Corp
    Grant or award
    		A—
    18.0K sh
    		Feb 25, 2026Feb 27, 2026
    traded Feb 25, 2026
    		+2dSEC FORM 4

    Evidence

    9
    AV
    Acurio VeronicaPresident, Orthodontics
    NVSTEnvista Holdings Corp
    Tax withholding
    		F$42K
    1,412 sh
    		Feb 25, 2026Feb 27, 2026
    traded Feb 25, 2026
    		+2dSEC FORM 4

    Evidence

    13
    AV
    Acurio VeronicaPresident, Orthodontics
    NVSTEnvista Holdings Corp
    Grant or award
    		A—
    7,605 sh
    		Feb 25, 2026Feb 27, 2026
    traded Feb 25, 2026
    		+2dSEC FORM 4

    Evidence

    9
    AV
    Acurio VeronicaPresident, Orthodontics
    NVSTEnvista Holdings Corp
    Grant or award
    		A—
    13.8K sh
    		Feb 25, 2026Feb 27, 2026
    traded Feb 25, 2026
    		+2dSEC FORM 4

    Evidence

    9
    AV
    Acurio VeronicaPresident, Orthodontics
    NVSTEnvista Holdings Corp
    Grant or award
    		A$23K
    998 sh
    		Feb 1, 2026Feb 3, 2026
    traded Feb 1, 2026
    		+2dSEC FORM 4

    Evidence

    21
    BR
    Befidi RobertPresident, Diagnostics
    NVSTEnvista Holdings Corp
    Grant or award
    		A$23K
    998 sh
    		Feb 1, 2026Feb 3, 2026
    traded Feb 1, 2026
    		+2dSEC FORM 4

    Evidence

    17
    KC
    Kaabi Faez CChief Accounting Officer
    NVSTEnvista Holdings Corp
    Grant or award
    		A$28K
    1,186 sh
    		Feb 1, 2026Feb 3, 2026
    traded Feb 1, 2026
    		+2dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    SEC Form 4
    Publisher
    U.S. Securities and Exchange Commission (EDGAR)
    Document ID
    0002045846-26-000007
    Machine-readable
    Structured copy

    Timestamps

    Event (reported)
    Aug 25, 2026
    Published
    Aug 27, 2026
    Ingested by INSIDER
    Nov 5, 02:20 UTC
    Last re-read
    Nov 5, 02:20 UTC

    Extracted facts

    Filer
    Acurio Veronica
    Role
    President, Orthodontics
    Transaction
    Tax withholdingAs filed: “F”
    Asset
    Envista Holdings Corp
    Ticker
    NVST
    Shares
    7,710
    Price per share
    $27.47
    Value
    $211,794
    Execution date (reported)
    Aug 25, 2026
    Owned after transaction
    48.8K shares
    Days from execution to publication
    2

    Calculation

    Value = shares × reported price per share

    • Shares: 7,710
    • Price: $27.47

    = $211,794

    What this establishes

    Acurio Veronica filed this Form 4 reporting a tax withholding of NVST on Aug 25, 2026. It became public on Aug 27, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

    Extraction

    Method
    Form 4 XML
    Confidence
    1.00
    President, Orthodontics
    Acurio Veronicacik:0002045846
    Issuer
    Envista Holdings Corpcik:0001757073

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.